Abstract
The incidence of OSAHS increased year by year, and OSAHS has become one of the major diseases that endangers human health. The pathogenesis of OSAHS is not yet entirely clear. As a novel adipokine, chemerin effects fat cells through autocrine, paracrine and endocrine in the body. It can promote adipocyte differentiation and lipolysis, affect glucose lipid metabolism and blood pressure regulation, and be involved in the body's immune response and inflammation. Chemerin is closely linked with OSAHS. We review the recent researches concerned about chemerin and OSAHS in this article. Key words: Obstructive sleep apnea hypopnea syndrome; Chemerin; Fat metabolism
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
